´ëÇÑ´ç´¢º´ÇÐȸ 2023 International Congress of Diabetes and Metabolism(2ÀÏÂ÷) : 2023-10-20
±³À°ÀÏÀÚ : 2023-10-20
±³À°Àå¼Ò : °æÁÖ È¹éÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ : 2023 International Congress of Diabetes and Metabolism(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071
À̸ÞÀÏ : diabetes@kams.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 1200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : °æ»óºÏµµ
±³À°½Ã°£ : 7 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 450,000¿ø
ºñ°í "»çÀüµî·Ï
Àü¹®ÀÇ: ȸ¿ø 28¸¸¿ø / ºñȸ¿ø 35¸¸¿ø
Àü°øÀÇ ¹× ºñÀÇ»ç: ȸ¿ø 18¸¸¿ø / ºñȸ¿ø 23¸¸¿ø
ÇöÀåµî·Ï
Àü¹®ÀÇ: ȸ¿ø 37¸¸¿ø / ºñȸ¿ø 45¸¸¿ø
Àü°øÀÇ ¹× ºñÀÇ»ç: ȸ¿ø 25¸¸¿ø / ºñȸ¿ø 27¸¸¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 20ÀÏ Room 3 (3F, HICO) 08:00~09:00 How to find optimal combination therapy for T2DM ÀÌ°æ¾Ö(ÀüºÏÀÇ´ë ³»°ú)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 4 (2F, HICO) 09:00~09:20 Clinical characteristics and treatment strategy of young-onset type 2 diabetes ¾ç¿¹½½(¼¿ï´ëÇб³Á÷ÀåºÎ¼ÓÀÇ¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 4 (2F, HICO) 09:20~09:40 Education strategies using new technology of diabetes care ½É°Èñ(»ï¼º¼¿ïº´¿ø °£È£°ú)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 4 (2F, HICO) 09:40~10:00 Application of special diet in young patients with diabetes Á¤À±¹Ì(°æÈñ´ëÇб³º´¿ø ¿µ¾ç°ú)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 4 (2F, HICO) 10:00~10:20 Exercise recommendations for young patients with diabetes Á¤½ÂÀç(»ï¼º¼¿ïº´¿ø ¿îµ¿)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 4 (2F, HICO) 10:20~10:40 Psychosocial evaluation and care tips for young patients with diabetes ±èÁØ¿µ(µ¿Åº¼º½Éº´¿ø »çȸ)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 1+2+3 (3F, HICO) 11:10~11:50 Novel insights regarding GLP-1 receptor agonist treatment Michael A Nauck(St. Josef Hospital Ruhr University Bochum Germany)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 1 (3F, HICO) 12:10~13:00 What¡¯s new? SGLT2 inhibitor ÀÓ¼ö(¼¿ïÀÇ´ë ³»°ú)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 3 (3F, HICO) 13:00~13:30 Why GLP1 therapy is important from pathophysiological perspective of T2D Michael A Nauck(St. Josef Hospital Ruhr University Bochum Germany)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 3 (3F, HICO) 13:30~14:00 How to integrate GLP-1RA into clinical practice ±è³²ÈÆ(°í·ÁÀÇ´ë ³»°ú)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 1+2+3 (3F, HICO) 15:00~15:40 Hepatic fibrosis - the silent threat of metabolic syndrome Scott Friedman(Icahn School of Medicine at Mount Sinai USA)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 3 (3F, HICO) 16:00~16:25 Machine learning approach to drug treatment strategy for diabetes care Kazuya Fujihara(Niigata University)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 3 (3F, HICO) 16:25~16:50 Prediction of type 2 diabetes using genome-wide polygenic risk score and metabolic profiles ÀÌÁ¤Çý(¼¿ï´ë °øÇÐÀü¹®´ëÇпø)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 3 (3F, HICO) 16:50~17:15 An artificial intelligence-based prediction model for diabetic kidney disease progression ±è³Èñ(°í·ÁÀÇ´ë ³»°ú)
±³À°½Ã°£ 10¿ù 20ÀÏ Room 3 (3F, HICO) 17:15~17:40 Electronic medical record–based machine learning approach to predict the risk of cardiovascular disease ÀüÅÂÁØ(¼¿ï¾Æ»êº´¿ø)